MK | EN

Ask question
Corporate
contact
Report of adverse
drug reactions
  • UNITED STATES OF AMERICA ALKALOID-RUS LLC
    + 7495 502 92 97
  • SWITZERLAND ALKALOID-RUS LLC
    + 7495 502 92 97
  • SERBIA ALKALOID-RUS LLC
    + 7495 502 92 97
  • SLOVENIA ALKALOID-RUS LLC
    + 7495 502 92 97
  • CROATIA ALKALOID-RUS LLC
    + 7495 502 92 97
  • RUSSIAN FEDERATION ALKALOID-RUS LLC
    + 7495 502 92 97
  • BULGARIA ALKALOID-RUS LLC
    + 7495 502 92 97
  • МONTENEGRO ALKALOID-RUS LLC
    + 7495 502 92 97
  • BOSNIA AND HERZEGOVINA ALKALOID-RUS LLC
    + 7495 502 92 97
  • ALBANIA ALKALOID-RUS LLC
    + 7495 502 92 97
  • KOSOVO ALKALOID-RUS LLC
    + 7495 502 92 97
  • TURKEY ALKALOID-RUS LLC
    + 7495 502 92 97
  • UKRAINE ALKALOID-RUS LLC
    + 7495 502 92 97

MK | EN

  • Company profile
    • About Alkaloid
      • History
      • In memoriam
      • Corporate structure
      • Standards and controls
      • Alkasap
      • Monograph
    • Address CEO
    • Environment protection
    • Corporate contacts
      • Alkaloid AD Skopje
      • Subsidiaries
    • Alkaloid KONS
  • Research and development
  • About investors
    • Financial reports
      • Annual financial reports
      • Interim financial reports
      • Financial indicators
    • Annual report
    • Investor news
    • Shareholders meeting
      • Shareholders meeting, April 2017
      • Shareholders meeting, April 2016
      • Shareholders meeting, April 2015
      • Shareholders meeting, April 2014
      • Shareholders meeting, April 2013
      • Shareholders meeting, April 2012
      • Shareholders meeting, April 2011
    • Data on shares
    • Contact
    • Links
  • Career
    • Alkaloid Today
      • Aspirations and values
      • Social Responsibility Policy of Alkaloid AD
      • Diversity
    • What We Offer
      • Benefits
      • Professional development
    • Your Career
      • Career in Alkaloid
      • Scholarships
    • Contact us
  • Мedia center
    • Video Gallery
      • „Path to success”, interview with the President of the Management Board and Chief Executive Officer of Alkaloid AD Skopje, Zhivko Mukaetov
  • Vademecum

Vademecum

Vademecum

Vademecum

Search:

  • Generic Name
  • Brand Name
  • Pharmaco-therapeutic Group
Alkaloid AD Skopje || Vademecum > Search group
Search by pharmaco-therapeutic group
  • Genito-urinary system and sex hormones
  • Various
  • Systemic hormonal preparations, excluding sex hormones and insulins
  • Antiinfectives for systemic use
  • Antineoplastic and immunomodulating agents
  • Antiparasitic products, insecticides and repellents
  • Alimentary tract and metabolism
  • Dermatologicals
  • Cardiovascular system
  • Blood and blood forming organs
  • Musckulo-skeletal system
  • Nervous system
  • Respiratory system
  • Sensory organs
  • Urologicals, drugs used in benign prostatic hypertrophy
  • Immunosuppressants
  • Antiinfectives for systemic use, other beta-lactam antibacterials
  • Antibiotics with broad spectrum of activity
  • Ophtalmologicals
  • Systemic hormonal preparations, excl. sex hormones and insulins

Pharmaceuticals

Botanicals

Cosmetics

Chemicals

Vademecum

Sitemap

©2014 - Alkaloid AD Skopje. All rights reserved